FierceBiotech Drug Development Forum
Event Sep 25 - Sep 27, 2017
Location: Boston, MA, USA
The FDA approved only 22 new drug candidates in 2016 – less than half of the prior year, and the lowest level since 2010. Meanwhile, the IPO market collapsed to its lowest level since 2009, and pressure from the government and payers is pushing pricing and value concerns into earlier stages of drug development.